Cure My Disease

Don't miss your cure!

 Log in / Sign up

App aims to cut Post-Surgery complications in digestive cancer patients

NCT ID NCT07558330

Symptom relief Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times

Summary

This study tests whether a smartphone app called MAELA® can help people recover better after surgery for digestive cancers. About 555 adults will use the app to report symptoms for 90 days after surgery, while doctors monitor alerts. The goal is to see if the app reduces serious complications and hospital readmissions compared to standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Expected to start

Nov 2026

An estimate. Start dates often move.

Expected to finish

Nov 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patient aged 18 years and older 2. Patient scheduled for digestive oncology surgery: 1. Colectomy for cancer 2. Pancreatectomy for cancer 3. Hepatectomy for cancer 4. Proctectomy for cancer 5. Gastrectomy for cancer 6. Esophagectomy for cancer 3. At least 2 weeks between scheduling and surgery 4. Patient with a smartphone (iOS or Android environment), or living with family members/primary caregivers who have a smartphone with access to cellular data/Wi-Fi 5. Subject affiliated with or beneficiary of a health insurance plan 6. Subject who can read and understand French 7. Subject who has signed informed consent Exclusion Criteria: 1. Patient already participating in an interventional clinical trial 2. Adult patient subject to a legal protection measure, guardianship, or deprived of liberty by a judicial or administrative decision 3. Patient unable to complete a questionnaire and without a close caregiver to support the use of the solution 4. Patient with a psychiatric disorder that would prevent them from giving informed consent or receiving optimal treatment and follow-up 5. Minor patient 6. Visually impaired patient 7. Patient with significant psychomotor disorders of the upper limbs 8. Patient with memory disorders 9. Patient without a mobile phone number 10. Patient without internet access 11. Pregnant or breastfeeding woman

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Digestive cancers are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

digestive system cancer digestive system neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Digestive cancers

Contacts and locations

Locations

  • CH Sud Francilien

    Corbeil-Essonnes, 91100, France

  • CHRU Nancy Brabois

    Nancy, 54500, France

  • CHU Rouen

    Rouen, 76000, France

  • Hôpital Nord

    Marseille, 13015, France

  • Hôpital Saint-Antoine

    Paris, 75012, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.